-
21-04-2023
11/2023 Estimated financial results and provisional recognition of contribution in kind value according to IFRS in financial statements
-
03-04-2023
10/2023 Medicalgorithmics subsidiary Kardiolytics' VCAST technology receives new U.S. patent for autonomous segmentation using artificial intelligence for vascular disease diagnosis
-
27-03-2023
9/2023 Notifications of transactions of persons discharging managerial responsibilities received in accordance with Article 19 of the MAR Regulation
-
08-03-2023
8/2023 Statement of KDPW on the conclusion of an agreement with the Company on registration of series I, J, K and L shares in the depository of securities
-
09-02-2023
7/2023 Notification of reducing the share below 5% of the total number of votes in the Company
-
03-02-2023
6/2023 Milestone of the Company's sales development strategy in the US market
-
31-01-2023
5/2023 Resignation of a member of the Company's Supervisory Board
-
23-01-2023
4/2023 Dates of publication of periodic reports in 2023
-
19-01-2023
3/2023 Medicalgorithmics Group introduces its solutions to the UK market
-
16-01-2023
2/2023 Medicalgorithmics US Holding Corporation received 3,0 mUSD of the IRS Tax Refund Amount from Medi-Lynx